IP Library › Granted Patent US 12,714,710
Granted Patent B2
US 12,714,710 · App. 17/757,483 · Granted Aug 25, 2026

Combinations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,714,710
App. No.
17/757,483
Granted
Aug 25, 2026
Kind
B2
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2022
From: ZENO MANAGEMENT, INC.
To: RECURIUM IP HOLDINGS, LLC
Reel/Frame 060708/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2022
From: SAMATAR, AHMED ABDI; LI, JIALI; HUANG, PETER QINHUA; BOREN, BRANT CLAYTON; BUNKER, KEVIN DUANE; DONATE, FERNANDO
To: ZENO MANAGEMENT, INC.
Reel/Frame 060708/0133 →
Continuity (2)
Provisional Application 62951991 · Dec 20, 2019
Related Publication 20230068370A1 · Mar 2, 2023
References Cited (131)
US 6063394A · Grosse-Bley et al. · 2000 [cited by applicant]
US 6617314B2 · Grosse-Bley et al. · 2003 [cited by applicant]
US 10292971B2 · Myles et al. · 2019 [cited by applicant]
US 11124518B2 · Huang et al. · 2021 [cited by applicant]
US 11251192B2 · Lee · 2022 [cited by applicant]
US 20060116364A1 · Hamaoka et al. · 2006 [cited by applicant]
US 20180072711A1 · Crew et al. · 2018 [cited by applicant]
US 20180170943A1 · Yu et al. · 2018 [cited by applicant]
US 20180291019A1 · Guan et al. · 2018 [cited by applicant]
US 20180318284A1 · Yang et al. · 2018 [cited by applicant]
US 20190337938A1 · Lu et al. · 2019 [cited by applicant]
US 20200017516A1 · Bastian et al. · 2020 [cited by applicant]
US 20200157112A1 · Huang et al. · 2020 [cited by applicant]
US 20210139482A1 · Huang et al. · 2021 [cited by applicant]
US 20210317124A1 · Huang et al. · 2021 [cited by applicant]
US 20220024939A1 · Huang et al. · 2022 [cited by applicant]
US 20230002426A1 · Huang et al. · 2023 [cited by applicant]
US 20230008362A1 · Samatar et al. · 2023 [cited by applicant]
US 20230054854A1 · Samatar et al. · 2023 [cited by applicant]
US 20230087941A1 · Samatar et al. · 2023 [cited by applicant]
US 20230210854A1 · Samatar et al. · 2023 [cited by applicant]
US 20230234956A1 · Huang et al. · 2023 [cited by applicant]
US 20230265097A1 · Hopkins et al. · 2023 [cited by applicant]
US 20240197743A1 · Pultar et al. · 2024 [cited by applicant]
US 20240261295A1 · Donate et al. · 2024 [cited by applicant]
US 20240299395A1 · Donate et al. · 2024 [cited by applicant]
US 20240325397A1 · Samatar et al. · 2024 [cited by applicant]
US 20240325412A1 · Donate et al. · 2024 [cited by applicant]
US 20240335447A1 · Donate et al. · 2024 [cited by applicant]
US 20240391924A1 · Huang et al. · 2024 [cited by applicant]
US 20240408097A1 · Samatar et al. · 2024 [cited by applicant]
CN 109843882A · 2019 [cited by applicant]
CN 109843888A · 2019 [cited by applicant]
JP 2017538725A · 2017 [cited by applicant]
RU 2017140674A · 2019 [cited by applicant]
WO WO9512383 · 1995 [cited by applicant]
WO WO9619997 · 1996 [cited by applicant]
WO WO9721440 · 1997 [cited by applicant]
WO WO9737653 · 1997 [cited by applicant]
WO WO9740823 · 1997 [cited by applicant]
WO WO9811902 · 1998 [cited by applicant]
WO WO2004058682 · 2004 [cited by applicant]
WO WO2012037410 · 2012 [cited by applicant]
WO WO2014130310 · 2014 [cited by applicant]
WO WO2014191726 · 2014 [cited by applicant]
WO WO2015095250 · 2015 [cited by applicant]
WO WO2016019634 · 2016 [cited by applicant]
WO WO2016097071 · 2016 [cited by applicant]
WO WO2016097072 · 2016 [cited by applicant]
WO WO2016176665 · 2016 [cited by applicant]
WO WO2016196337 · 2016 [cited by applicant]
WO WO2016202161 · 2016 [cited by applicant]
WO WO2017059139 · 2017 [cited by applicant]
WO WO2017080338 · 2017 [cited by applicant]
WO WO2017100712 · 2017 [cited by applicant]
WO WO2017100715 · 2017 [cited by applicant]
WO WO2017107754 · 2017 [cited by applicant]
WO WO2017136688 · 2017 [cited by applicant]
WO WO2017172957 · 2017 [cited by applicant]
WO WO2017182493 · 2017 [cited by applicant]
WO WO2017182495 · 2017 [cited by applicant]
WO WO2017216279 · 2017 [cited by applicant]
WO WO2017216280 · 2017 [cited by applicant]
WO WO2018001232 · 2018 [cited by applicant]
WO WO2018019793 · 2018 [cited by applicant]
WO WO2018077260 · 2018 [cited by applicant]
WO WO2018077630 · 2018 [cited by applicant]
WO WO2018081168 · 2018 [cited by applicant]
WO WO2018091153 · 2018 [cited by applicant]
WO WO2018097273 · 2018 [cited by applicant]
WO WO2018102725 · 2018 [cited by applicant]
WO WO2018130123 · 2018 [cited by applicant]
WO WO2018130124 · 2018 [cited by applicant]
WO WO2018138303 · 2018 [cited by applicant]
WO WO2018148576 · 2018 [cited by applicant]
WO WO2019028008 · 2019 [cited by applicant]
WO WO2019066692 · 2019 [cited by applicant]
WO WO2019139899 · 2019 [cited by applicant]
WO WO2019139900 · 2019 [cited by applicant]
WO WO2019139902 · 2019 [cited by applicant]
WO WO2019139907 · 2019 [cited by applicant]
WO WO2019165204 · 2019 [cited by applicant]
WO WO2019173082 · 2019 [cited by applicant]
WO WO2019223715 · 2019 [cited by applicant]
WO WO2019245974 · 2019 [cited by applicant]
WO WO2020014440 · 2020 [cited by applicant]
WO WO2020210320 · 2020 [cited by applicant]
WO WO2021097139 · 2021 [cited by applicant]
WO WO2021127044 · 2021 [cited by applicant]
WO WO2021127045 · 2021 [cited by applicant]
WO WO2021127047 · 2021 [cited by applicant]
WO WO2021231653 · 2021 [cited by applicant]
WO WO2021252667 · 2021 [cited by applicant]
WO WO2022011391 · 2022 [cited by applicant]
WO WO2022136916 · 2022 [cited by applicant]
WO WO2022221143 · 2022 [cited by applicant]
WO WO2022251224 · 2022 [cited by applicant]
WO WO2022271731 · 2022 [cited by applicant]
WO WO2023064282 · 2023 [cited by applicant]
WO WO2023076485 · 2023 [cited by applicant]
WO WO2023114871 · 2023 [cited by applicant]
WO WO2023114875 · 2023 [cited by applicant]
WO WO2023114877 · 2023 [cited by applicant]
WO WO2024031048 · 2024 [cited by applicant]
WO WO2024059696 · 2024 [cited by applicant]
WO WO2024059808 · 2024 [cited by applicant]
WO WO2024102649 · 2024 [cited by applicant]
WO WO2024102650 · 2024 [cited by applicant]
WO WO2024249756 · 2024 [cited by applicant]
WO WO2025076311 · 2025 [cited by applicant]
Mayo Clinic (Year: 2024). [cited by examiner]
Korczyn AD. Why have we Failed to Cure Alzheimer's Disease? Journal of Alzheimer's Disease. 2012;29(2):275-282. doi: 10.3233/JAD-2011-110359 (Year: 2012). [cited by examiner]
Wells PG, et al. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol Appl Pharmacol. Sep. 1, 2005;207(2 Suppl):354-66. doi: 10.1016/j.taap.2005.01.061. (Year: 2005). [cited by examiner]
Jyoti B, et al. Pregnancy on tamoxifen: Case-report and review of literature. South Asian J Cancer. Oct.-Dec. 2016;5(4):209-210. doi: 10.4103/2278-330X.195347. PMID: 28032092; PMCID: PMC5184762. (Year: 2016). [cited by examiner]
Nathan et al., A Review of Fulvestrant in Breast Cancer. Oncol Ther. 2017;5(1):17-29. doi: 10.1007/s40487-017-0046-2. Epub May 8, 2017 (Year: 2017). [cited by examiner]
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537 (Year: 1999). [cited by examiner]
Kato et al., Menopausal estrogen therapy and non-Hodgkin's lymphoma: A post-hoc analysis of women's health initiative randomized clinical trial. Int J Cancer. Feb. 1, 2016;138(3):604-11. doi: 10.1002/ijc.29819. Epub Sep… [cited by examiner]
Extended European Search Report dated Dec. 5, 2023 for EP Application No. 20903410.7, filed Dec. 16, 2020. [cited by applicant]
Patel et al., “Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors” Breast Cancer Res. (2019) 21(1):146. [cited by applicant]
Office Action dated Oct. 25, 2024 for CN Application No. 202080095164.0, filed Dec. 16, 2020. [cited by applicant]
First Examination Report dated Sep. 5, 2024 for NZ Application No. 790033, filed Dec. 16, 2020. [cited by applicant]
Office Action dated Jul. 16, 2024 for RU Application No. 2022118426, filed Dec. 16, 2020. [cited by applicant]
Office Action dated Sep. 12, 2024 for TW Application No. 109145123, filed Dec. 18, 2020. [cited by applicant]
Alluri et al., “Estrogen receptor mutations and their role in breast cancer progression” Breast Cancer Research (2014) 16:494. [cited by applicant]
Geenan et al., “Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer” Clincal Cancer Research (2017) 23(16):4540-4544. [cited by applicant]
International Search Report and Written Opinion mailed Feb. 3, 2021 for PCT Application No. PCT/US2020/065401, filed Dec. 16, 2020. [cited by applicant]
International Preliminary Report on Patentability issued May 17, 2022 for PCT Application No. PCT/US2020/065401, filed Dec. 16, 2020. [cited by applicant]
Office Action drafted Apr. 6, 2025 for IL Application No. 294074, filed Dec. 16, 2020. [cited by applicant]
Office Action drafted Dec. 2, 2024 for JP Application No. 2022-538216, filed Dec. 16, 2020. [cited by applicant]
Examination Report dated Mar. 5, 2025 for NZ Application No. 790033, filed Dec. 16, 2020. [cited by applicant]
Office Action dated Jan. 27, 2025 for RU Application No. 2022118426, filed Dec. 16, 2020. [cited by applicant]